InSilicoTrials

Milan, Italy Founded: 2016 • Age: 10 yrs
Healthcare simulation services are provided for medical applications worldwide.
Request Access

About InSilicoTrials

InSilicoTrials is a company based in Milan (Italy) founded in 2016.. InSilicoTrials has raised $3.5 million across 2 funding rounds from investors including United Ventures, Pi Campus and UniCredit Start Lab. InSilicoTrials offers products and services including Simulation Platform and Computational Models. InSilicoTrials operates in a competitive market with competitors including Revolution Medicine, CONTINUUM India, Generable, Chrestos and Incite Health, among others.

  • Headquarter Milan, Italy
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3.5 M (USD)

    in 2 rounds

  • Latest Funding Round
    $3.5 M (USD), Series A

    Jul 27, 2020

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of InSilicoTrials

InSilicoTrials offers a comprehensive portfolio of products and services, including Simulation Platform and Computational Models. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Cloud platform for AI-based drug development simulations

Tools integrating models to reduce R&D costs and time

People of InSilicoTrials
Headcount 10-50
Employee Profiles 9
Employee Profiles
People
Vincenzo Carbone, PhD
Head Of R&i
People
Luca Emili
CEO
People
Mario Torchia
Chief Operating Officer
People
Roberta Bursi, PhD, PMP
Chief Scientific Officer

Unlock access to complete

Funding Insights of InSilicoTrials

InSilicoTrials has successfully raised a total of $3.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.5 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $3.5M
  • First Round
  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2020 Amount Series A - InSilicoTrials Valuation United Ventures
Jun, 2020 Amount Grant - InSilicoTrials Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in InSilicoTrials

InSilicoTrials has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include United Ventures, Pi Campus and UniCredit Start Lab. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Investments are directed toward early-growth SaaS and digital companies.
Founded Year Domain Location
Early-stage AI startups are funded and supported by Pi Campus.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by InSilicoTrials

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - InSilicoTrials

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Insilicotrials Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of InSilicoTrials

InSilicoTrials operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Revolution Medicine, CONTINUUM India, Generable, Chrestos and Incite Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Delivers comprehensive pharmacogenomic testing services for personalized medical solutions.
domain founded_year HQ Location
Offers pharmacovigilance, regulatory, evidence evaluation, and technology solutions to pharma firms.
domain founded_year HQ Location
Precision medicine is delivered via statistical machine learning models.
domain founded_year HQ Location
Pharmacokinetic and pharmacodynamic study services are offered by this CRO.
domain founded_year HQ Location
Clinical laboratory specializing in immune system testing and pharmacogenomics services for clinical trials
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Insilicotrials

Frequently Asked Questions about InSilicoTrials

When was InSilicoTrials founded?

InSilicoTrials was founded in 2016 and raised its 1st funding round 4 years after it was founded.

Where is InSilicoTrials located?

InSilicoTrials is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.

Is InSilicoTrials a funded company?

InSilicoTrials is a funded company, having raised a total of $3.5M across 2 funding rounds to date.

What does InSilicoTrials do?

InSilicoTrials was established in 2016 in Milan, Italy, within the healthcare technology sector. Simulation services are offered to model clinical trials and drug development processes using computational methods. Operations center on in silico approaches to assist pharmaceutical and biotech firms in reducing experimental needs. The companys domain, insilicotrials.com, supports its digital platform for service delivery across Europe and beyond.

Who are the top competitors of InSilicoTrials?

InSilicoTrials's top competitors include Chrestos, Incite Health and CONTINUUM India.

What products or services does InSilicoTrials offer?

InSilicoTrials offers Simulation Platform and Computational Models.

Who are InSilicoTrials's investors?

InSilicoTrials has 3 investors. Key investors include United Ventures, Pi Campus, and UniCredit Start Lab.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available